Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Multiple Sclerosis l: Introduction

Multiple Sclerosis l: Introduction

Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Long-term remission of neuromyelitis optica with allogeneic hematopoietic stem cell transplant.

Med (New York, N.Y.)·2026

Same author

Extracellular Vesicle-Associated IL4 Displays Enhanced Anti-Inflammatory Properties in Microglial Cells.

Journal of extracellular biology·2026

Same author

Plasma central nervous system biomarkers in heavily treatment-experienced people with HIV in the PRESTIGIO registry.

AIDS (London, England)·2026

Same author

A roadmap for supporting the development of advanced therapy medicinal products in a European framework.

The Lancet regional health. Europe·2026

Same author

Translating neurofilament light chain testing into clinical practice: a multidisciplinary implementation roadmap.

Clinical chemistry and laboratory medicine·2026

Same author

Duloxetine ameliorates cerebral ischemic injury by inhibiting autophagy.

Autophagy·2026

Search research articles

Related Experiment Video

Updated: Jun 23, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Modeling Multiple Sclerosis in the Two Sexes: MOG_35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Animal models of multiple sclerosis.

Roberto Furlan¹, Carmela Cuomo, Gianvito Martino

¹Neuroimmunology Unit - DIBIT and Department of Neuroscience, San Raffaele Scientific Institute, Milan, Italy.

Methods in Molecular Biology (Clifton, N.J.)

|April 21, 2009

Summary

Experimental autoimmune encephalomyelitis (EAE) is a key animal model for studying central nervous system inflammation and demyelination, crucial for multiple sclerosis research and treatment development.

Area of Science:

Neuroimmunology
Demyelinating Diseases
Preclinical Research

Background:

Experimental autoimmune encephalomyelitis (EAE), initially called experimental allergic encephalitis, is a widely used animal model.
It is instrumental in investigating the pathogenesis and treatment of central nervous system inflammation and demyelination.
EAE has become the predominant animal model for multiple sclerosis (MS) research over the past three decades.

Purpose of the Study:

To review the immunological characteristics of EAE across various animal species and strains.
To provide detailed protocols for inducing common clinical courses of EAE in mice.
To establish a foundation for the effective utilization of the EAE model in research.

Main Methods:

Review of immunological features of EAE in different species and strains.

More Related Videos

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

Related Experiment Videos

Last Updated: Jun 23, 2026

Modeling Multiple Sclerosis in the Two Sexes: MOG35-55-Induced Experimental Autoimmune Encephalomyelitis

Modeling Multiple Sclerosis in the Two Sexes: MOG_35-55-Induced Experimental Autoimmune Encephalomyelitis

Published on: October 13, 2023

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Rat Model of Widespread Cerebral Cortical Demyelination Induced by an Intracerebral Injection of Pro-Inflammatory Cytokines

Published on: September 21, 2021

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Induction of Experimental Autoimmune Encephalomyelitis in Mice and Evaluation of the Disease-dependent Distribution of Immune Cells in Various Tissues

Published on: May 8, 2016

Detailed protocol descriptions for inducing EAE in mice.

Analysis of EAE's utility in preclinical studies, including nonhuman primates.

Main Results:

EAE is applicable across various mammalian models, enabling advanced preclinical studies.
The model has demonstrated predictive value, contributing to the development of approved MS treatments.
Experiments in EAE have validated neural precursor cells (NPCs) as a therapeutic strategy for CNS inflammation.

Conclusions:

EAE is a valuable and versatile model for multiple sclerosis research.
Proper application of the EAE model aids in developing effective treatments for CNS demyelinating diseases.
This review offers practical guidance for researchers using EAE in preclinical studies.